§ COMPOUND PROFILE · INDEPENDENT RESEARCH18 TESTS · AVG 99.50% · 219 SHOPS
◆ COMPOUND · WEIGHT LOSS & METABOLIC
Weight Loss & Metabolic

Mazdutide

Dual GLP-1/glucagon receptor agonist developed by Innovent Biologics, in clinical trials for obesity and metabolic liver disease.

Peptigrity tracks Mazdutide across 219 shops with 18 independent lab tests and an average HPLC purity of 99.50%.

Avg. HPLC purity99.50%
Lab tests on file18
Shops selling219

Lab test results

18 tests · AVG 99.50%
◆ CROSS-SHOP COMPARISON · SORTED BY DATE12 of 18 SHOWN
Date
Shop
Purity
Qty (labeled → tested)
Endotoxins
Lab
Feb 12, 2026
99.42%
10mg9.96mg-0.4%
-
Feb 3, 2026
99.70%
10mg10.29mg+2.9%
-
Nov 12, 2025
99.83%
10mg10.46mg+4.6%
-
Aug 30, 2025
99.92%
10mg10mg+0%
-
Aug 15, 2025
99.17%
15mg16.63mg+10.9%
-
Aug 2, 2025
99.77%
10mg10.41mg+4.1%
-
May 29, 2025
99.10%
10mg10.17mg+1.7%
-
Apr 9, 2025
99.61%
15mg16.89mg+12.6%
-
Apr 8, 2025
99.72%
10mg11.15mg+11.5%
-
Jan 28, 2025
99.98%
6mg7.64mg+27.3%
-
Jan 4, 2025
99.90%
5mg6.026mg+20.5%
-

Shops selling Mazdutide

219 verified · top 6 shown

What Is Mazdutide

Mechanism & research

Dual GLP-1/glucagon receptor agonist developed by Innovent Biologics, in clinical trials for obesity and metabolic liver disease.

Mazdutide vs other peptides

Same category · Lab-verified
Compound
Mechanism
Avg purity
Tests
Compare
Mazdutide→ This page
GLP-1 / Glucagon dual-agonist
99.50%
18
GLP-1 / GIP / Glucagon triple-agonist
99.65%
610
GLP-1 / GIP dual-agonist
99.57%
575
GLP-1 receptor agonist
99.65%
238
Mitochondrial-derived metabolic peptide
99.43%
233
Long-acting amylin receptor agonist
99.64%
161
Compared on independent lab purityBrowse all Weight Loss & Metabolic

Related peptides

Same category
● COMMUNITY VERIFICATION

Have a lab test for Mazdutide?

Every submitted test helps the community verify purity across brands. Free, fast, independent.

Submit a test →